Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

Published on July 8, 2024
CELL_Ft image Blog_Building blocks

The whitepaper, a collaboration between the Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), summarizes a Scientific Exchange held on November 1, 2023.  This event brought together CGT developers, FDA staff, and industry stakeholders to discuss development and regulatory challenges in the CGT field and identify reusable "building blocks" that could streamline processes and improve efficiency.

 

 

Continue reading on website
Other news

Unveiling Ncardia's Path to Innovation and Growth

July 5, 2024
In this interview, we spoke to Dr. Jeroen de Groot, Ncardia’s new Divisional Chief Executive, about the past and the future of Ncardia. Continue reading to uncover Ncardia's exciting innovations and don't miss Dr. Jeroen de Groot's exclusive hint on what's ahead for the company this year!BACKGROUNDDr. Jeroen de Groot has a robust background in leading international contract research organizations

How Norstella is embedding artificial intelligence to improve pipeline to patient decision-making

July 8, 2024
As drug discovery becomes more complex, expensive, and challenging, it is imperative for companies to innovate to stay ahead. Scientific advancements and the latest drug technologies are an important response, but artificial intelligence is poised to revolutionize the decision making at the heart of R&D (in)efficiency. Norstella and its constituent brands – Citeline, Evaluate, MMIT, […]